Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
February 12 2024 - 11:30AM
Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical
technology company, will showcase its latest technologies across
the orthopedic care continuum at the American Academy of Orthopedic
Surgeons Annual Meeting 2024. In addition, the Company will present
itself as a newly integrated company following the acquisition of
orthopedic leader LimaCorporate S.p.A (“Lima”).
“Enovis has a lot to be excited about in 2024. In our Surgical
business, the addition of Lima brings great technologies,
capabilities and a product portfolio with demonstrated clinical
excellence around the world. Our newly combined sales channel has
size, scale and global market access which is extremely powerful,”
stated Louie Vogt, Group President of Enovis Recon. "2024 will also
be a banner year for product innovation and our ability to improve
patient outcomes. We’re launching more new products than ever
before with significant introductions across shoulders, knees and
hips.”
With the addition of Lima, Enovis will present its extensive and
newly integrated portfolio of implant technologies, pre- and
post-operative care solutions and digital care resources that help
clinicians provide the best care to their patients:
- ARVIS® Augmented Reality - The ARVIS®
Augmented Reality System represents the next era of orthopedic
technology. This wearable, self-contained system delivers real-time
surgical guidance at the point of care and has recently been
updated with simpler registration.
- AltiVate® Anatomic Augmented Glenoid -
Maximize your solutions with AltiVate® Anatomic Augmented Glenoid.
The most recent addition to the AltiVate® portfolio that features
the Standard, Symmetric augment, and Half-Wedge augment now also
includes the Full-Wedge augment option. This entire line of
augmented glenoids boasts immediate fixation through patented
Drop-and-Go® technology and longevity with the e+™ vitamin E
blended polyethylene.
- EMPOWR 3D Knee® - Medial pivot is only half
the story. The latest studies have shown that the native knee moves
medially in late flexion, but laterally in early flexion, including
walking.2 The EMPOWR 3D Knee® creates more natural motion with the
first and only dual pivot total knee design on the market.3,4
- EMPOWR™ blade stem – The recently launched
EMPOWR™ blade stem accounted for previous design challenges with
legacy blade and wedge stems and creates a modern stem designed for
more fit and more efficiency.
- DynaNail Helix™- The DynaNail Helix™ is
designed to achieve sustained dynamic compression for subtalar
fusion with an innovative, anatomically friendly design and simple,
screw-like insertion.
- Evolve34™ - Evolve34™ is a bunion solution for
Lapidus correction that allows surgeons to dial in deformity
correction and select a hardware construct specific for the
patient’s needs.
- Pecaplasty® - From the recently acquired
Novastep® portfolio, Pecapasty® is a guided instrumentation and
implant platform for percutaneous bunion correction. The
Pecaplasty® System delivers a long-awaited solution, designed for
precise realignment, accurate stabilization, and reproducible
outcomes.
- DonJoy® ROAM™ OA Knee Brace - The latest
innovation in unloader knee braces from Enovis' DJO, LLC
subsidiary, the new DonJoy ROAM OA knee brace helps improve
mobility and dynamically provides relief by unloading the pressure
of unicompartmental osteoarthritis or other knee pain. Comfortable
and easy to use with lightweight, low-profile joint unloading and
support, ROAM is ideal for conservative care in active patients,
patients looking for support in daily living, in preparation for
surgery or for post-operative meniscal tears when indicated.
Visit AAOS booth #1827 or www.enovis.com to learn how Enovis is
developing innovative medical technology that continues to
revolutionize the orthopedic industry.
About EnovisEnovis Corporation (NYSE: ENOV) is
an innovation-driven, medical technology growth company dedicated
to developing clinically differentiated solutions that generate
measurably better patient outcomes and transform workflows. Powered
by a culture of continuous improvement, global talent and
innovation, the Company’s extensive range of products, services,
and integrated technologies fuels active lifestyles in orthopedics
and beyond. For more information about Enovis, please visit
www.enovis.com
Media Contact
Katie Sweet
Vice President, Corporate Communications
Katie.Sweet@enovis.com
References
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924521/AJRR
reference of Linear longevity
- Report on file with Enovis Surgical, IRPD-2023-0018
- Melinda K. Harman, Stephanie J. Bonin, Chris J. Leslie, Scott
A. Banks, and W. Andrew Hodge, “Total Knee Arthroplasty Designed to
Accommodate the Presence or Absence of the Posterior Cruciate
Ligament,” Advances in Orthopedics, vol. 2014, Article ID 178156, 8
pages, 2014.
- Meneghini, R. M., Deckard, E. R., Ishmael, M. K., &
Ziemba-Davis, M. (2017). A dual-pivot pattern simulating native
knee kinematics optimizes functional outcomes after total knee
arthroplasty. The Journal of Arthroplasty, 32(10), 3009–3015.
https://doi.org/10.1016/j.arth.2017.04.050
- Sandberg, Rory, et al. "Dual-pivot bearings improve ambulation
and promote increased activity levels in Total knee arthroplasty: A
match-controlled retrospective study." The Knee 26.6 (2019):
1243-1249.
Enovis (NYSE:ENOV)
Historical Stock Chart
From Sep 2024 to Oct 2024
Enovis (NYSE:ENOV)
Historical Stock Chart
From Oct 2023 to Oct 2024